start portlet menu bar end portlet menu bar

Measurement of safety parameters of simultaneous administration of two vaccines against mastitis

Hjem Viden Measurement of safety parameters of simultaneous administration of two vaccines against mastitis

Measurement of safety parameters of simultaneous administration of two vaccines against mastitis

This study presents the findings on safety of a simultaneous administration of STARTVAC® and UBAC® vaccines in lactating cows.

Download denne artikel

134 KB

Om denne artikel

Udgivet i

National Mastitis Council, 2018

Dato

10. jul. 2018

Forfattere

Baratelli, M.; Boix-Mas, O.; Franco Zalduendo, D.; Pochodyla, M.

Resume

Simultaneous administration of STARTVAC® and UBAC® do not induce adverse reaction out of specification of the Specific Product Characteristics.

Lignende produkter

UBAC®

STARTVAC® - TOPVAC®

Lignende publikationer

Efficacy under field conditions of the new vaccine UBAC® in the reduction of Streptococcus uberis clinical mastitis in dairy cows during a whole lactation period Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response) Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

Del

start portlet menu bar

Measurement of safety of two vaccines against mastitis

Display portlet menu
end portlet menu bar

Se også

Publikationer

Efficacy under field conditions of the new vaccine UBAC® in the reduction of Streptococcus...

10-07-2018
Post

Udder Health by HIPRA and CowSignals: 1 + 1 = 3

12-05-2017
Nyheder

HIPRA presents UBAC®, the only specific vaccine against Strep. uberis

28-06-2018